Caregen Co Ltd
KOSDAQ:214370
Intrinsic Value
Caregen Co., Ltd. engages in the development of cosmetic products. [ Read More ]
The intrinsic value of one Caregen Co Ltd stock under the Base Case scenario is 25 182.04 KRW. Compared to the current market price of 21 400 KRW, Caregen Co Ltd is Undervalued by 15%.
Valuation Backtest
Caregen Co Ltd
Run backtest to discover the historical profit from buying and selling Caregen Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Caregen Co Ltd
Current Assets | 166.4B |
Cash & Short-Term Investments | 132.7B |
Receivables | 14.2B |
Other Current Assets | 19.5B |
Non-Current Assets | 80.8B |
Long-Term Investments | 3.8B |
PP&E | 64B |
Intangibles | 4.7B |
Other Non-Current Assets | 8.4B |
Current Liabilities | 11.3B |
Accounts Payable | 889.8m |
Accrued Liabilities | 2.4B |
Other Current Liabilities | 8B |
Non-Current Liabilities | 8.7B |
Other Non-Current Liabilities | 8.7B |
Earnings Waterfall
Caregen Co Ltd
Revenue
|
79.2B
KRW
|
Cost of Revenue
|
-20.8B
KRW
|
Gross Profit
|
58.4B
KRW
|
Operating Expenses
|
-18B
KRW
|
Operating Income
|
40.4B
KRW
|
Other Expenses
|
-448.1m
KRW
|
Net Income
|
39.9B
KRW
|
Free Cash Flow Analysis
Caregen Co Ltd
Profitability Score
Profitability Due Diligence
Caregen Co Ltd's profitability score is 72/100. The higher the profitability score, the more profitable the company is.
Score
Caregen Co Ltd's profitability score is 72/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Caregen Co Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Score
Caregen Co Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Caregen Co Ltd
According to Wall Street analysts, the average 1-year price target for Caregen Co Ltd is 51 000 KRW with a low forecast of 50 500 KRW and a high forecast of 52 500 KRW.
Shareholder Return
Price
Caregen Co Ltd
Average Annual Return | 46.43% |
Standard Deviation of Annual Returns | 61.01% |
Max Drawdown | -61% |
Market Capitalization | 1.1T KRW |
Shares Outstanding | 49 134 240 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Caregen Co., Ltd. engages in the development of cosmetic products. The company is headquartered in Anyang, Gyeonggi-Do. The company went IPO on 2015-11-17. The firm manufactures HSR CEs which used for improving facial wrinkles and strengthening protect wet under the brand name of Dermaheal, aquashines which used for keeping the shin whitening and promoting skin cells activation under the brand name of REVOFIL, HL CEs which used for treating hair loss, hair filler excell C'rums which used for promoting hair growth and preventing hair lose, LL CEs which used for promoting fat decomposition and prevent fat accumulation, hydra B5 Gels, ultra AW500s, eye filler masks, efficacy raw materials including growth facors and biomimetic peptides, and others. The firm distributes its products within domestic market and to overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one Caregen Co Ltd stock under the Base Case scenario is 25 182.04 KRW.
Compared to the current market price of 21 400 KRW, Caregen Co Ltd is Undervalued by 15%.